DXCM · 10-Q · 2026Q3 · Full report

Capital Expenditure Outlook

DEXCOM INC · 2026-10-29 · Importance 34 · Surprise 42 · In source text

Dexcom expects significant capital expenditures over the next year for equipment and continued investment in manufacturing facilities. Long-term capital requirements also include development of manufacturing facilities and office spaces. The company expects to fund these requirements from cash, short-term investments, operating cash flows, and available credit, and expects to allocate at least 50% of cash generated from operations, net of planned capital expenditures, to share repurchases over its long-range plan.

Key facts

Dexcom expects significant capital expenditures over the next year as it continues investing in equipment and manufacturing facilities. source
Dexcom anticipates significant expenditures for build-out of manufacturing facilities and equipment investment. source

Impact estimates

metric	direction	stage	expected	basis
cash	negative	probable	—	Dexcom expects significant capital expenditures over the next year as it continues investing in equipment and manufacturing facilities.